GSK’s R&D chief to leave for UK gov role?
GlaxoSmithKline’s head of R&D Patrick Vallance is reportedly leaving the firm to take on the role of chief scientific advisor at the government. According to the Financial Times, which cited “two people briefed on the situation”, Vallance will also become head of the Government Office for Science, to boost the quality of scientific evidence and advice in government.